Evolution of Burkholderia pseudomallei in Recurrent Melioidosis

Burkholderia pseudomallei, the etiologic agent of human melioidosis, is capable of causing severe acute infection with overwhelming septicemia leading to death. A high rate of recurrent disease occurs in adult patients, most often due to recrudescence of the initial infecting strain. Pathogen persistence and evolution during such relapsing infections are not well understood. Bacterial cells present in the primary inoculum and in late infections may differ greatly, as has been observed in chronic disease, or they may be genetically similar. To test these alternative models, we conducted whole-genome comparisons of clonal primary and relapse B. pseudomallei isolates recovered six months to six years apart from four adult Thai patients. We found differences within each of the four pairs, and some, including a 330 Kb deletion, affected substantial portions of the genome. Many of the changes were associated with increased antibiotic resistance. We also found evidence of positive selection for deleterious mutations in a TetR family transcriptional regulator from a set of 107 additional B. pseudomallei strains. As part of the study, we sequenced to base-pair accuracy the genome of B. pseudomallei strain 1026b, the model used for genetic studies of B. pseudomallei pathogenesis and antibiotic resistance. Our findings provide new insights into pathogen evolution during long-term infections and have important implications for the development of intervention strategies to combat recurrent melioidosis.

[1]  H. Schweizer,et al.  Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei , 2011, Proceedings of the National Academy of Sciences.

[2]  N. Day,et al.  Survival of Burkholderia pseudomallei in distilled water for 16 years , 2011, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[3]  S. Peacock,et al.  Melioidosis: a clinical overview. , 2011, British medical bulletin.

[4]  N. Day,et al.  Survey of Antimicrobial Resistance in Clinical Burkholderia pseudomallei Isolates over Two Decades in Northeast Thailand , 2011, Antimicrobial Agents and Chemotherapy.

[5]  Christine Fong,et al.  Bioinformatics Applications Note Genome Analysis Pgat: a Multistrain Analysis Resource for Microbial Genomes , 2022 .

[6]  R. Bonomo,et al.  Molecular investigations of PenA-mediated beta-lactam resistance inBurkholderia pseudomallei , 2011 .

[7]  R. Bonomo,et al.  Molecular Investigations of PenA-mediated β-lactam Resistance in Burkholderia pseudomallei , 2011, Front. Microbio..

[8]  M. Voskuil,et al.  Adaptation and Antibiotic Tolerance of Anaerobic Burkholderia pseudomallei , 2011, Antimicrobial Agents and Chemotherapy.

[9]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[10]  J. Heesemann,et al.  Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. , 2010, International journal of medical microbiology : IJMM.

[11]  C. Wolz,et al.  Adaptation of Staphylococcus aureus to the cystic fibrosis lung. , 2010, International journal of medical microbiology : IJMM.

[12]  Damian Szklarczyk,et al.  The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored , 2010, Nucleic Acids Res..

[13]  Edouard E Galyov,et al.  Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis. , 2010, Annual review of microbiology.

[14]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[15]  J. Hacker,et al.  Bacterial genome plasticity and its impact on adaptation during persistent infection. , 2010, International journal of medical microbiology : IJMM.

[16]  T. West,et al.  Burkholderia Type VI Secretion Systems Have Distinct Roles in Eukaryotic and Bacterial Cell Interactions , 2010, PLoS pathogens.

[17]  M. Hecker,et al.  Host Imprints on Bacterial Genomes—Rapid, Divergent Evolution in Individual Patients , 2010, PLoS pathogens.

[18]  David G. Russell,et al.  Tuberculosis: What We Don’t Know Can, and Does, Hurt Us , 2010, Science.

[19]  H. Schweizer,et al.  A Burkholderia pseudomallei ΔpurM Mutant Is Avirulent in Immunocompetent and Immunodeficient Animals: Candidate Strain for Exclusion from Select-Agent Lists , 2010, Infection and Immunity.

[20]  Wing-Kin Sung,et al.  A Genomic Survey of Positive Selection in Burkholderia pseudomallei Provides Insights into the Evolution of Accidental Virulence , 2010, PLoS pathogens.

[21]  Amy J. Vogler,et al.  Within-Host Evolution of Burkholderia pseudomallei in Four Cases of Acute Melioidosis , 2010, PLoS pathogens.

[22]  M. Cullinane,et al.  The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease? , 2009, FEMS microbiology reviews.

[23]  E. Feil,et al.  Burkholderia pseudomallei Is Genetically Diverse in Agricultural Land in Northeast Thailand , 2009, PLoS neglected tropical diseases.

[24]  Linus Sandegren,et al.  Bacterial gene amplification: implications for the evolution of antibiotic resistance , 2009, Nature Reviews Microbiology.

[25]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[26]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[27]  S. Puthucheary,et al.  Variations in Ceftazidime and Amoxicillin-Clavulanate Susceptibilities within a Clonal Infection of Burkholderia pseudomallei , 2009, Journal of Clinical Microbiology.

[28]  W. Nierman,et al.  Simple sequence repeat (SSR)-based gene diversity in Burkholderia pseudomallei and Burkholderia mallei , 2009, Molecules and cells.

[29]  R. Durbin,et al.  Mapping Quality Scores Mapping Short Dna Sequencing Reads and Calling Variants Using P

, 2022 .

[30]  Donald Woods,et al.  The Core and Accessory Genomes of Burkholderia pseudomallei: Implications for Human Melioidosis , 2008, PLoS pathogens.

[31]  Samuel I. Miller,et al.  Burkholderia thailandensis as a Model System for the Study of the Virulence-Associated Type III Secretion System of Burkholderia pseudomallei , 2008, Infection and Immunity.

[32]  David A. D'Argenio,et al.  Large-insert genome analysis technology detects structural variation in Pseudomonas aeruginosa clinical strains from cystic fibrosis patients. , 2008, Genomics.

[33]  Joshua M. Korn,et al.  Mapping and sequencing of structural variation from eight human genomes , 2008, Nature.

[34]  M. Schell,et al.  Targeted Mutagenesis of Burkholderia thailandensis and Burkholderia pseudomallei through Natural Transformation of PCR Fragments , 2008, Applied and Environmental Microbiology.

[35]  Raymond K. Auerbach,et al.  A Horizontal Gene Transfer Event Defines Two Distinct Groups within Burkholderia pseudomallei That Have Dissimilar Geographic Distributions , 2007, Journal of bacteriology.

[36]  Amy J. Vogler,et al.  VNTR analysis of selected outbreaks of Burkholderia pseudomallei in Australia. , 2007, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[37]  Lynn Y. Huynh,et al.  Tandem repeat regions within the Burkholderia pseudomallei genome and their application for high resolution genotyping , 2007, BMC Microbiology.

[38]  Lars Jelsbak,et al.  Molecular Epidemiology and Dynamics of Pseudomonas aeruginosa Populations in Lungs of Cystic Fibrosis Patients , 2007, Infection and Immunity.

[39]  K. Stepniewska,et al.  Risk factors for recurrent melioidosis in northeast Thailand. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  H. Schweizer,et al.  Method for Regulated Expression of Single-Copy Efflux Pump Genes in a Surrogate Pseudomonas aeruginosa Strain: Identification of the BpeEF-OprC Chloramphenicol and Trimethoprim Efflux Pump of Burkholderia pseudomallei 1026b , 2006, Antimicrobial Agents and Chemotherapy.

[41]  B. Spratt,et al.  Nonrandom Distribution of Burkholderia pseudomallei Clones in Relation to Geographical Location and Virulence , 2006, Journal of Clinical Microbiology.

[42]  R. Fulton,et al.  The complete genome sequence of a chronic atrophic gastritis Helicobacter pylori strain: evolution during disease progression. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[43]  S. Peacock,et al.  Management of melioidosis , 2006, Expert review of anti-infective therapy.

[44]  David A. D'Argenio,et al.  Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[45]  D. Falush,et al.  Genomic Changes during Chronic Helicobacter pylori Infection , 2006, Journal of bacteriology.

[46]  A. Cheng,et al.  Recurrent Melioidosis in Patients in Northeast Thailand Is Frequently Due to Reinfection Rather than Relapse , 2005, Journal of Clinical Microbiology.

[47]  Raquel Tobes,et al.  The TetR Family of Transcriptional Repressors , 2005, Microbiology and Molecular Biology Reviews.

[48]  G. Crawford,et al.  Cutaneous Melioidosis in a Man Who Was Taken as a Prisoner of War by the Japanese during World War II , 2005, Journal of Clinical Microbiology.

[49]  Kim Rutherford,et al.  Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[50]  O. White,et al.  Structural flexibility in the Burkholderia mallei genome. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[51]  D. DeShazer Genomic Diversity of Burkholderia pseudomallei Clinical Isolates: Subtractive Hybridization Reveals a Burkholderia mallei-Specific Prophage in B. pseudomallei 1026b , 2004, Journal of bacteriology.

[52]  Asger Dirksen,et al.  Stability of DNA patterns and evidence of Mycobacterium tuberculosis reactivation occurring decades after the initial infection. , 2003, The Journal of infectious diseases.

[53]  Richard A. Moore,et al.  Burkholderia pseudomallei Class A β-Lactamase Mutations That Confer Selective Resistance against Ceftazidime or Clavulanic Acid Inhibition , 2003, Antimicrobial Agents and Chemotherapy.

[54]  David Gordon,et al.  Viewing and Editing Assembled Sequences Using Consed , 2003, Current protocols in bioinformatics.

[55]  B. Spratt,et al.  Multilocus Sequence Typing and Evolutionary Relationships among the Causative Agents of Melioidosis and Glanders, Burkholderia pseudomallei and Burkholderia mallei , 2003, Journal of Clinical Microbiology.

[56]  J A Eisen,et al.  The Genome of the Natural Genetic Engineer Agrobacterium tumefaciens C58 , 2001, Science.

[57]  C. Desmarais,et al.  Automated finishing with autofinish. , 2001, Genome research.

[58]  D. Fisher,et al.  Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis. , 2001, International journal of antimicrobial agents.

[59]  P. Green,et al.  Base-calling of automated sequencer traces using phred. I. Accuracy assessment. , 1998, Genome research.

[60]  P Green,et al.  Base-calling of automated sequencer traces using phred. II. Error probabilities. , 1998, Genome research.

[61]  R. Hancock,et al.  Susceptibility to beta-lactam antibiotics of Pseudomonas aeruginosa overproducing penicillin-binding protein 3 , 1997, Antimicrobial agents and chemotherapy.

[62]  R. Carlyon,et al.  Mutagenesis of Burkholderia pseudomallei with Tn5-OT182: isolation of motility mutants and molecular characterization of the flagellin structural gene , 1997, Journal of bacteriology.

[63]  B. Currie,et al.  RAPD analysis of isolates of Burkholderia pseudomallei from patients with recurrent melioidosis , 1995, Epidemiology and Infection.

[64]  D. Palmer,et al.  Melioidosis. Forgotten, but not gone! , 1991, Archives of internal medicine.

[65]  G. Gutman,et al.  Slipped-strand mispairing: a major mechanism for DNA sequence evolution. , 1987, Molecular biology and evolution.

[66]  E. Mays,et al.  Melioidosis: recrudescence associated with bronchogenic carcinoma twenty-six years following initial geographic exposure. , 1975, Chest.

[67]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.